Trial intelligence / Profile preview

Botulax vs Botox for Glabellar Lines

NCT01791920Phase 3Completed

Sponsor
Hugel
Start
Aug 2011
Primary completion
Dec 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of botulinum toxin type A in glabellar lines, sponsored by Hugel. Started Aug 2011; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

glabellar lines

Beyond the preview

Go deeper on NCT01791920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01791920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call